Search

everythinglearnresearchcommunity

for

Search:↓

Cinchonine Nanostructured Lipid Carriers serum safely and effectively stimulates hair growth and increases the number and size of hair follicles.

The combination of laser and topical steroids is more effective for treating alopecia areata than topical steroids alone.

A woman with alopecia totalis regrew dark hair in bands after using a corticosteroid ointment.

PRP injections significantly improve hair regrowth in alopecia areata.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Etanercept, a psoriasis treatment, caused hair loss in a patient.

The document concludes that scalp conditions have various causes and can present in many different ways.

A man with severe hair loss regrew hair after hormone treatment.

An 86-year-old man with prostate cancer was diagnosed with a rare, low-grade breast cancer and underwent surgery but declined additional hormone therapy.

Babies born after 38 weeks to mothers under 36 years old and not delivered by C-section have a higher risk of neonatal occipital alopecia.

Effective treatments for common hair loss are limited and may have side effects, leading to patient disappointment and treatment discontinuation.

Diagnosing and treating rapidly worsening lung disease is difficult and requires better guidelines and understanding.

Ludwig pattern hair loss results from varying androgen sensitivity, causing fewer thick hairs and more thin hairs.

Cyclosporin doesn't stop hair loss.

Hair loss can cause significant social and emotional issues, especially for women and young men.

The treatment improved hair growth and thickness in patients with hair loss, even 10 months after therapy without additional products.

Lab tests for female hair loss have unclear usefulness; consider based on symptoms.

Hair loss and excessive growth treated with various options, including new laser technology.

Hair follicle biology advancements may lead to better hair growth disorder treatments.

Hair loss common in Australia; men affected earlier, more often than Asians; women less concerned.

Melatonin may benefit skin health and could be a promising treatment in dermatology.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

The BASP classification is a detailed and accurate way to categorize hair loss in both men and women.

Turing patterns are now recognized as important in developmental biology.

Using nanostructured lipid carriers to deliver spironolactone could improve treatment for hair loss.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Activating the Wnt/β-catenin pathway could lead to new hair loss treatments.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.